Simplex Trading
BLRX

Simplex Trading’s BioLineRX BLRX Stock Holding History

Simplex Trading’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,000
Closed -$13K – 9073
2025
Q2 		$13K Buy
+3,000
New +$11.1K ﹤0.01% 7089
2024
Q4 		– Sell
-78
Closed -$1K – 8529
2024
Q3 		$1K Buy
78
+8
+11% +$220 ﹤0.01% 8138
2024
Q2 		$1K Hold
70
– – ﹤0.01% 8423
2024
Q1 		$3K Sell
70
-2,590
-97% -$130K ﹤0.01% 8220
2023
Q4 		$167K Sell
2,660
-1,165
-30% -$72.1K ﹤0.01% 4842
2023
Q3 		$278K Buy
3,825
+1,922
+101% +$129K ﹤0.01% 4009
2023
Q2 		$121K Buy
+1,903
New +$105K ﹤0.01% 4848
2022
Q2 		– Sell
-45
Closed -$3K – 9975
2022
Q1 		$3K Sell
45
-8
-15% -$557 ﹤0.01% 9661
2021
Q4 		$4K Buy
53
+35
+194% +$3.65K ﹤0.01% 9642
2021
Q3 		$2K Hold
18
– – ﹤0.01% 9501
2021
Q2 		$1K Buy
+18
New +$2.12K ﹤0.01% 9795

Other funds holding BLRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's BLRX Position: Q4 2025 in Review

Simplex Trading sold out of BioLineRX (BLRX) in Q4 2025, closing a stake of 105 shares.

Simplex Trading first reported a position in BLRX in Q4 2021 and held it in 8 quarters. The position peaked at $64K in Q2 2025. 14 funds tracked by Wall St. Rank hold BLRX as of Q4 2025.

  • Simplex Trading reported no remaining BioLineRX position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 105 BioLineRX shares in Q4 2025.
  • Simplex Trading first reported a position in BioLineRX in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's BioLineRX position peaked at $64K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.